glp 1 drugs contraindications Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Spencer JP, Thomas S, Trondsen Pawlowski RH

Danuglipron increased insulin levels in primates but not rodents, which was explained by receptor mutagensis studies and a cryogenic electron microscope structure that revealed a binding pocket requiring a primate-specific tryptophan 33 residue

The clinically most relevant and important action of DPP-4 inhibitors is the endogenous elevation of the incretin hormone concentration of GLP-1 that consecutively leads to a glucose-dependent stimulation of insulin secretion and an inhibition of glucagon secretion (10)

Expert analysis of GLP-1 vs dual GLP-1/glucagon therapy options